Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escitalopram for depression in HIV+ women
NCT01797380Phase 4Terminated
- Sponsor
- Duke University
- Start
- Jan 2008
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Escitalopram oxalate oral solution in major depressive disorder (MDD), sponsored by Duke University. Started Jan 2008; status: terminated.
02
Drugs
Escitalopram oxalate oral solution
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01797380.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01797380.